Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase
about
MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 bindingActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesA comprehensive pathway map of epidermal growth factor receptor signalingStructural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2UVB Stimulates the Expression of Endothelin B Receptor in Human Melanocytes via a Sequential Activation of the p38/MSK1/CREB/MITF Pathway Which Can Be Interrupted by a French Maritime Pine Bark Extract through a Direct Inactivation of MSK1ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functionsCodependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survivalNa+/H+ exchanger isoform 1 induced cardiomyocyte hypertrophy involves activation of p90 ribosomal s6 kinase.The UVB-Stimulated Expression of Transglutaminase 1 Is Mediated Predominantly via the NFκB Signaling Pathway: New Evidence of Its Significant Attenuation through the Specific Interruption of the p38/MSK1/NFκBp65 Ser276 Axis.The C-terminal kinase and ERK-binding domains of Drosophila S6KII (RSK) are required for phosphorylation of the protein and modulation of circadian behavior.Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury.A clickable inhibitor reveals context-dependent autoactivation of p90 RSKRibosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling.Structural bioinformatics-based design of selective, irreversible kinase inhibitors.MSK1 activity is controlled by multiple phosphorylation sites.Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate.The historical Coffin-Lowry syndrome family revisited: identification of two novel mutations of RPS6KA3 in three male patients.Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner.
P2860
Q24302401-97C877B6-1A7F-4F76-BC2E-1E61E80B1DCDQ24632768-00C4E8C7-6E22-43A1-A427-226296A16CCBQ24672490-D94F62E1-273C-4063-A895-CD4DC8BC4255Q27649349-3C7AE554-87B9-4111-B580-64C3F0B7E8A1Q27658416-55F52224-05A9-4F63-95CA-30A8BF84E822Q28262690-B13CE6C7-96CE-4F4D-9945-B5C0C0FC5931Q29615216-B5C3E5DA-719C-424A-83CE-ACBA52FBC789Q30438715-FAFD1039-CC14-441B-A2CF-CAAA242F3C53Q35591765-E9CF5942-32AD-4D2F-B2B3-564503A02D72Q35754457-0112E394-114C-4EAA-9D54-4FF94D0C127FQ35956694-C327D429-AD00-4892-920B-F455EA7C74F1Q36419214-D45CC6D4-3F18-41F6-95FF-D88DFE239DA1Q36769105-48B9CA0C-DF07-4A64-AC84-AA336A370BDFQ36790127-9E5B777B-E7BA-40C0-8B2D-4FC57A8230E3Q37104693-E3F4E9CA-FFF8-4884-AEBE-3FAA62625227Q40307105-2F86934F-0F91-4A87-AEF0-BDCB92CEEF71Q40487132-2EBEEE5A-1A4E-4064-80AA-67FC3A8D614DQ45287586-D402C0BE-A7BC-4570-A27F-DF932AD133F5Q54336333-7E38CEA6-9866-484E-BB51-555D0FF8008FQ54508038-D9ECF989-6E03-47E5-88FA-3643C83F10EF
P2860
Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase
description
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2002
@ast
im August 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/08/02)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/08/02)
@nl
наукова стаття, опублікована в серпні 2002
@uk
name
Characterization of the p90 ri ...... nal domain as a protein kinase
@ast
Characterization of the p90 ri ...... nal domain as a protein kinase
@en
Characterization of the p90 ri ...... nal domain as a protein kinase
@nl
type
label
Characterization of the p90 ri ...... nal domain as a protein kinase
@ast
Characterization of the p90 ri ...... nal domain as a protein kinase
@en
Characterization of the p90 ri ...... nal domain as a protein kinase
@nl
prefLabel
Characterization of the p90 ri ...... nal domain as a protein kinase
@ast
Characterization of the p90 ri ...... nal domain as a protein kinase
@en
Characterization of the p90 ri ...... nal domain as a protein kinase
@nl
P2860
P356
P1476
Characterization of the p90 ri ...... nal domain as a protein kinase
@en
P2093
Carol A. Chrestensen
Thomas W. Sturgill
P2860
P304
27733–27741
P356
10.1074/JBC.M202663200
P407
P577
2002-08-02T00:00:00Z